Articles in regional publications that pertain to a wide range of North Carolina-related topics.
Search Results
14 results
for "University of North Carolina at Chapel Hill. Lineberger Comprehensive Cancer Research Center"
Currently viewing results 1 - 14
|
PAGE
OF 1
|
Record #:
25912
Author(s):
Abstract:
Breast cancer advocates are changing how research gets done by lobbying for increased funding, helping decide what gets funded, and even evaluating research products such as drugs. New research directions at UNC include the Specialized Programs in Research Excellence, which unites researchers, clinicians, and patients in advancing breast cancer studies.
Source:
Subject(s):
Full Text:
Record #:
25826
Author(s):
Abstract:
UNC researchers hope that by 2050, genetic analysis will help family doctors predict which people will inherit genetic mutations or predispositions to cancer. Genetic research might also show how patients will react to chemotherapy or medication so that doses can be better regulated, and may speed the testing of new targeted therapies and novel means of early detection.
Source:
Subject(s):
Full Text:
Record #:
1057
Author(s):
Abstract:
Researchers at the University of North Carolina at Chapel Hill have found that \"good\" cancer cells can, by means of intra-tumor communication, effectively prevent \"bad\" cancer cells from spreading. This is a novel approach to cancer treatment.
Source:
Subject(s):
Record #:
25718
Author(s):
Abstract:
UNC encourages physicians to consider conducting trials at their clinics. Clinical trials are necessary to advance research and treatment, but recruiting patients is difficult if they think a drug is being tested on them. For liver-cancer patient Don Yarborough, participating in a trial was crucial. If the treatment does not help him, he said, maybe the research would help someone else.
Source:
Subject(s):
Full Text:
Record #:
25551
Author(s):
Abstract:
Ned Sharpless is a UNC associate professor of medicine and genetics. Sharpless devised a blood test to measure the p16 protein, a tumor suppressor that builds up in cells as people age. The p16 test could keep cells from becoming cancerous, as well as predict how patients would handle surgery or how well wounds would heal.
Source:
Subject(s):
Full Text:
Record #:
36295
Author(s):
Abstract:
Reported as among the top ten research universities in the United States, UNC Chapel Hill’s research endeavors has greatly impacted treatment measures for diseases such as cancer, postpartum depression, and diabetes. Such accomplishments possible through partnerships with corporations, as well as personalized treatments and targeted therapies.
Source:
Subject(s):
University of North Carolina at Chapel Hill; University of North Carolina at Chapel Hill--Research; University of North Carolina at Chapel Hill. Lineberger Comprehensive Cancer Research Center; IBM; Genetics--Research; Postpartum depression; Cancer--Medical care; Cancer--Research; University of North Carolina at Chapel Hill. School of Medicine; Diabetes--Prevention; Job creation--North Carolina; Economic development
Record #:
25791
Author(s):
Abstract:
Nitric Oxide is a molecule that helps maintain the body’s critical functions. According to biochemist Mark Schoenfisch, nitric oxide could be used to treat ovarian cancer and other diseases.
Source:
Subject(s):
Full Text:
Record #:
25864
Author(s):
Abstract:
Researchers recently conducted surveys for the North Carolina BEAUTY (Bringing Education and Understanding To You) Project, a four-year health and cancer intervention study in salons in eight North Carolina counties. The study is assessing whether stylists can be used as health promoters, communicating messages of health in salons.
Source:
Subject(s):
Full Text:
Record #:
25789
Author(s):
Abstract:
Treating certain kinds of life-threatening cancer is difficult because oncologists do not know all the genetic abnormalities that underpin the disease. UNC scientists are now part of a nationwide effort to understand all the genetic changes that occur in cancer, and are currently focusing on brain tumors.
Source:
Subject(s):
Full Text:
Record #:
25502
Author(s):
Abstract:
UNC medicinal chemist Jian Jin created a molecular probe which may help to develop more effective treatments for cocaine addiction, mental retardation, HIV, and various types of cancer. The probe is freely available to the scientific community so that others may improve or expand upon the research.
Source:
Subject(s):
Full Text:
Record #:
26061
Author(s):
Abstract:
James Raleigh, a professor of radiation oncology and toxicology, invented the hypoxia marker to detect cells lacking oxygen. Hypoxia is indicated by special antibodies that Raleigh developed, which appears green in a photomicrograph. Raleigh and other researchers are learning that hypoxia plays a role in many diseases and processes in the body other than cancer.
Source:
Subject(s):
Full Text:
Record #:
26031
Author(s):
Abstract:
Proteomics is a new field that focuses on the properties and activities of individual proteins. Researchers are exploring ways of combining proteomics with genetics to learn how cells function, change, and interact. Proteomics is also being used in cystic fibrosis and cancer research, and in the discovery of novel drug targets.
Source:
Subject(s):
Full Text:
Record #:
26104
Author(s):
Abstract:
Julian Rosenman, professor of radiation oncology who specializes in lung cancer, is interested in making radiation doses more accurate and faster to calculate. Rosenman was previously a physicist and has discovered a way to break radiation beams into hundreds of little beamlets.
Source:
Subject(s):
Full Text:
Record #:
667
Author(s):
Abstract:
Cancer researchers at UNC's Lineberger Cancer Research Center are helping to cripple the cancer disease.
Source:
Subject(s):